Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Dalgleish

Showing results (71-80 of 222) with videos related to

Pageof 23
Sort By:
Integrative Cancer Therapies|March 31, 2007
Disease regression in malignant melanoma: spontaneous resolution or a result of treatment with antioxidants, green tea, and pineapple cores? A case reportAgnieszka Michael, Bijan Hedayati, A G Dalgleish
Seminars in Oncology|September 11, 1999
Gene therapy for prostate cancerD Hrouda, M Perry, A G Dalgleish
British Journal of Cancer|July 20, 2000
Differential and antagonistic effects of 9-cis-retinoic acid and vitamin D analogues on pancreatic cancer cells in vitroF Pettersson, K W Colston, A G Dalgleish
Pancreas|October 9, 2001
Retinoic acid enhances the cytotoxic effects of gemcitabine and cisplatin in pancreatic adenocarcinoma cellsF Pettersson, K W Colston, A G Dalgleish
Immunology Today|November 24, 1999
Thalidomide as an emerging immunotherapeutic agentJ B Marriott, G Muller, A G Dalgleish
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 29, 2009
How immunotherapy can enhance the response to other modalities and improve outcome and quality of lifeW M Liu, B Meyer, A G Dalgleish
Drugs & Aging|August 5, 2000
Prospects for vaccination in prostate cancerM J Perry, D Hroulda, A G Dalgleish
Lancet (London, England)|April 7, 1990
HIV envelope glycoprotein, antigen specific T-cell responses, and soluble CD4F Manca, J A Habeshaw, A G Dalgleish
Postgraduate Medical Journal|November 1, 1991
Coeliac disease presenting with cerebellar degenerationR A Hermaszewski, S Rigby, A G Dalgleish
Lancet (London, England)|April 19, 1986
AIDS, Portugal, and AfricaA G Dalgleish, M Malkovsky, A D Webster
Pageof 23

Showing results (71-80 of 222) with videos related to

Sort By:
Pageof 23
Integrative Cancer Therapies|March 31, 2007
Disease regression in malignant melanoma: spontaneous resolution or a result of treatment with antioxidants, green tea, and pineapple cores? A case reportAgnieszka Michael, Bijan Hedayati, A G Dalgleish
Seminars in Oncology|September 11, 1999
Gene therapy for prostate cancerD Hrouda, M Perry, A G Dalgleish
British Journal of Cancer|July 20, 2000
Differential and antagonistic effects of 9-cis-retinoic acid and vitamin D analogues on pancreatic cancer cells in vitroF Pettersson, K W Colston, A G Dalgleish
Pancreas|October 9, 2001
Retinoic acid enhances the cytotoxic effects of gemcitabine and cisplatin in pancreatic adenocarcinoma cellsF Pettersson, K W Colston, A G Dalgleish
Immunology Today|November 24, 1999
Thalidomide as an emerging immunotherapeutic agentJ B Marriott, G Muller, A G Dalgleish
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 29, 2009
How immunotherapy can enhance the response to other modalities and improve outcome and quality of lifeW M Liu, B Meyer, A G Dalgleish
Drugs & Aging|August 5, 2000
Prospects for vaccination in prostate cancerM J Perry, D Hroulda, A G Dalgleish
Lancet (London, England)|April 7, 1990
HIV envelope glycoprotein, antigen specific T-cell responses, and soluble CD4F Manca, J A Habeshaw, A G Dalgleish
Postgraduate Medical Journal|November 1, 1991
Coeliac disease presenting with cerebellar degenerationR A Hermaszewski, S Rigby, A G Dalgleish
Lancet (London, England)|April 19, 1986
AIDS, Portugal, and AfricaA G Dalgleish, M Malkovsky, A D Webster
Pageof 23